Author: Business Wire

Aerie Pharmaceuticals Reports Initial RhopressaTM Phase 3 Efficacy Results

IRVINE, Calif. & BEDMINSTER, N.J. & RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with glaucoma and other diseases of the eye, today reported the results of its first Phase 3 registration trial (Rocket 1) for RhopressaTM, a novel once-daily, triple-action eye drop being tested for its ability to

Prestige Brands Announces Ron Lombardi to Succeed Matt Mannelly as President and Chief Executive Officer

TARRYTOWN, N.Y.–(BUSINESS WIRE)–Prestige Brands Holdings, Inc. (NYSE:PBH) announced today that Matthew M. Mannelly, President and Chief Executive Officer and member of the Board of Directors, will retire effective June 1, 2015. Following his retirement, the Board of Directors has appointed Ron Lombardi, Chief Financial Officer, to succeed Mr. Mannelly as President and Chief Executive Officer. The company has commenced a search for a new Chief Financial Officer. “Ron and Matt have worked toget

Clarity Medical’s RetCam Will Be Used in a Worldwide Clinical Study for the Treatment of Premature Infant Ocular Disease

PLEASANTON, Calif.–(BUSINESS WIRE)–Clarity Medical Systems, Inc., a developer and marketer of ophthalmic diagnostic imaging technologies, is pleased to announce that their product, RetCam, will be utilized to image premature infant eyes in a study to evaluate a potential new method for treating Retinopathy of Prematurity (ROP) using Lucentis™ (ranibizumab). “The use of RetCam in a study of this medical significance demonstrates the growing worldwide acceptance of RetCam for pediatric retinal